WILLIAM K PLUNKETT JR to Cyclin-Dependent Kinase 2
This is a "connection" page, showing publications WILLIAM K PLUNKETT JR has written about Cyclin-Dependent Kinase 2.
Connection Strength
0.192
-
Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myeloma. J Clin Oncol. 2010 Jun 20; 28(18):3015-22.
Score: 0.083
-
Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial. Blood. 2006 Mar 15; 107(6):2517-24.
Score: 0.061
-
Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine. Mol Pharmacol. 2002 Sep; 62(3):680-8.
Score: 0.048